Equisolon contains prednisolone as the active substance which is an intermediate acting corticosteroid. It is indicated for the alleviation of inflammatory and clinical parameters associated with recurrent airway obstruction in horses, in combination with environmental control. Recurrent airway obstruction (RAO) is a commonly occurring respiratory disease in mature horses. Affected horses are susceptible to inhaled antigens and other pro-inflammatory agents, including fungal spores and dust-derived endotoxin. Where medical treatment of horses with RAO is required, glucocorticoids are effective in controlling clinical signs and decreasing neutrophilia in airways.
Container of 180 g
100 mg prednisolone, 300 mg prednisolone, 600 mg prednisolone